Biplr Im En Pac Leads (430-07, 432-03, 436-02 & 07, 438-05 & 07)
510(k) K962174
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)ST | NumberK962174 | Date21 Aug 1996 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- ST
Overview
AI-generated summary, 18 Sep 2026
The Bipolar Implantable Endocardial Pacing Leads are classified as Permanent Pacemaker Electrodes, designed to deliver electrical stimulation to the myocardium for long-term cardiac pacing. These bipolar leads facilitate precise pacing by connecting to implantable pulse generators, ensuring reliable electrical conduction within the heart.
These leads are supplied sterile and intended for single-use implantation. They are regulated under FDA 510(k) clearance (K962174) as a Class 3 device, with a product code of DTB. Each model (430-07, 432-03, 436-02 & 07, 438-05 & 07) is tracked individually, adhering to substantial equivalence requirements for permanent pacemaker electrodes.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are these leads reusable or intended for single-use only, and how should they be handled before implantation?
These leads are explicitly designed for single-use only and are supplied sterile by the manufacturer. They must remain in their sterile packaging until immediately before implantation to ensure proper infection control and functionality.
What models are available, and how do they differ in terms of application or design?
The Bipolar Implantable Endocardial Pacing Leads come in five distinct models: 430-07, 432-03, 436-02 & 07, and 438-05 & 07. While the exact differences in design or application aren’t specified, each model is tracked individually under FDA regulations, indicating potential variations in lead characteristics (e.g., length, electrode configuration, or pacing thresholds) tailored for specific clinical needs.
How should these leads be stored, and what are the key considerations for maintaining their integrity?
Since these leads are sterile and single-use, they should be stored in their original, unopened packaging in a clean, dry environment away from direct sunlight or extreme temperatures. The packaging must remain intact until use to preserve sterility and prevent contamination.
What regulatory pathway was followed for FDA clearance, and how does this affect their use in clinical settings?
These leads were cleared via the FDA 510(k) process (K962174) under the Class 3 device classification, with a product code of DTB (Permanent Pacemaker Electrodes). This means they underwent a premarket submission to demonstrate substantial equivalence to a legally marketed predicate device, ensuring compliance with safety and performance standards for long-term cardiac pacing applications.